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This table describes the immunization schedule for US-bound refugees, and includes vaccines given as part of the new CDC-PRM expanded immunization 
program in Kenya, Ethiopia, Uganda, Thailand, Malaysia and Nepal (shaded boxes). As part of this program: 
 Refugees will receive up to 2-4 doses of a vaccine series based on time before departure. IOM will take previous vaccine history into account if 
reliable and available and document this on the DS 3025 form.    
 First doses of all vaccines are given at the overseas medical screening exam, approximately 3-6 months before departure for most refugees.    
 Most second doses of vaccine are given 2 months after the first dose.  
 Refugees who undergo repeated medical examinations overseas may receive additional doses of vaccine. 
 No routine live virus vaccines will be administered by IOM within 4 weeks prior to departure except in special outbreak settings. CDC will provide 
additional notification in these situations. 
 New Technical Instructions for Polio Vaccination apply to refugees.  More information is available at 
http://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/technical-instructions-polio-vaccination-applicants-us-immigration.html. 
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 (started Nov 2013) 
Kenya
2
 (started Sept 2013) 
Malaysia
3
 (started Sep 2013) 
Nepal
4
 (started Dec 2012) 
Thailand
5
 (started Dec 2012) 
Uganda
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6 wks -<7 yrs  
 
 















 x 2 (2nd dose  in urban 
refugees only)* 
 







IOM will attempt to complete the series of each 
vaccine shown in the previous column if time permits  
 
Polio vaccine 
 tOPV (virus types 1, 2, 3)  is used in all countries 
except Malaysia, and counts towards U.S. polio 
vaccine requirements.  
 When IPV becomes available for older children in 
Malaysia, it will be administered for children up to 




 Administration of 2 doses of MMR began in March 



































1 Principal refugee groups resettling from Ethiopia include Eritreans (Shimelba camp); Somalis (Kebribeya camp); Multiple (Addis Ababa)  
2
 Principal refugee groups resettling from Kenya include Somalis (Dadaab camps); Somalis, Sudanese, Congolese (Kakuma camp); Multiple (Nairobi)  
3
 Principal refugee group resettling from Malaysia is Burmese (multiple ethnicities, primarily Chin)  
4
 Principal refugee group resettling from Nepal is Bhutanese 
5
 Principal refugee group resettling from Thailand is Burmese (multiple ethnicities, primarily Karen) 
6
 Principal refugee groups resettling from Uganda are Congolese and Somalis 
 
 










(containg DTP,Hib,HepB) x 2  
(2
nd
 dose  in urban refugees 
only); see individual vaccine 
components for specific details 
 
IPV x 2 given as part of either 
hexavalent vaccine containing 
DTP+IPV+Hib+HepB or Infanrix 
DTP-IPV vaccine in Malaysia.  
OPV and standalone IPV are 
not available in Malaysia at 
this time. 
 
2013 in Ethiopia. 
 In Malaysia, from Sept 2011 to Feb 2013, children 
6-11 mos received 1 dose of MMR as part of a 
measles outbreak response. 
 
Hep B Vaccine 
 Testing for hepatitis B virus infection (HBsAg) prior 
to vaccination began in Thailand and Nepal from 
Jan 2014 and in Malaysia starting July 2014.  All 




 When available, PCV-13 will be given to children 6 
wks -<5 yrs of age.  A second dose will be given to 
children up to age 2 yrs.  One dose of PCV-13 will 
also be given to all immunocompromised persons 
regardless of age. 
 
Hib vaccine 
 One dose of Hib vaccine will be given to 
unimmunized asplenic persons regardless of age 




 In Uganda, Td vaccine procurement may be 
delayed initially.  We expect this situation to be 
resolved shortly. 
Tanzania ≥ 1 yr - 
Born ≥ 1957 
MMR x1 One dose of MMR is administered at time of initial 
health assessment (approximately 2-6 months before 
arrival in U.S.) 
Iraq 
Jordan 
6 wks-10 yrs tOPV x1 tOPV administration started in January 2014 in both 
countries 
7 
MMR = measles, mumps, rubella; bOPV = bivalent (types 1 and 2) oral polio vaccine; tOPV = trivalent ( types 1, 2 and 3) Hep B = hepatitis b; DTP = diphtheria, tetanus, 
pertussis; Hib = Haemophilus influenzae type b 
8 
Dose #2 DTP will be given to children 15 mos-7 yrs residing in urban areas only.  Children residing in refugees camps often receive DTP as part of routine vaccination by 
the camp health care provider.  As part of the resettlement vaccination program, these children will receive only 1 dose of DTP or pentavalent (DTP-Hib-HepB) from 
IOM in order to reduce the risk of adverse local reactions due to over-vaccination with DTP. 
 
